Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SITC 2021 | Mechanism of action of AV-GBM-1 vaccine

Daniela Bota, MD, PhD, The University of California, Irvine, Irvine, CA, explains the mechanism of action of the AV-GBM-1 vaccine, a dendritic cell vaccine derived from glioblastoma stem cells. This interview took place during the 36th Society for Immunotherapy of Cancer (SITC) Annual Meeting in Washington, D.C.